Plain-English translation of NCT05464992 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new imaging method called CEST (Chemical Exchange Saturation Transfer) that can be added to standard PET/MRI scans of the brain. The technique provides detailed biochemical information about brain tumors, helping doctors better understand the nature and characteristics of gliomas (primary brain cancers) and brain metastases (cancers that have spread to the brain). By adding this extra imaging sequence, researchers hope to improve how doctors diagnose and monitor these serious conditions.
Current brain imaging techniques provide important structural information, but this new technique could reveal more about the chemical makeup of tumors, potentially helping doctors better distinguish between different types of tumors and detect recurrence earlier. This research aims to improve diagnostic accuracy and patient outcomes for people with brain cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive the standard PET/MRI scan that your doctor has already recommended as part of your cancer care. The only addition is an extra imaging sequence (CEST) that takes a small amount of additional scanning time during your regular appointment. There are no extra visits, medications, or procedures involved—this is simply an enhancement to imaging you would be receiving anyway.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
France